Table 1.
Cytokine | Effect | Volume pasteurized (mL) | Pooled (number of donors) | Reference |
---|---|---|---|---|
IL-2 | – | 119 | Yes (4) | (49) |
– | <10 | No | (65) | |
↓ (47%) | <50 | No | (125) | |
IL-4 | – | 119 | Yes (4) | (49) |
– | <10 | No | (65) | |
↓ (>70%) | <50 | No | (125) | |
IL-5 | – | 119 | Yes (4) | (49) |
– | <10 | No | (65) | |
↓ (>45%) | <50 | No | (125) | |
IL-12 | – | 20 | Yes (6) | (45) |
– | 119 | Yes (4) | (49) | |
– | <10 | No | (65) | |
↓ (42%) | <50 | No | (125) | |
IL-13 | – | 119 | Yes (4) | (49) |
– | <10 | No | (65) | |
↓ (>90%) | Not specified | No | (99) | |
IL-17 | – | 20 | Yes (6) | (45) |
– | <10 | No | (65) | |
MIP-1β | ↓ | <10 | No | (65) |
EPO | ↓ | Not specified | No | (126) |
IL-1β | ↓ | 119 | Yes (4) | (49) |
↓ (>70%) | <50 | No | (125) | |
– | <10 | No | (65) | |
IL-6 | ↓ (75%) | 20 | Yes (6) | (45) |
↓ | Not specified | No | (99) | |
↓ (>50%) | <50 | No | (125) | |
– | <10 | No | (65) | |
IL-10 | ↓ (24%) | 20 | Yes (6) | (45) |
↓ | 119 | Yes (4) | (49) | |
↓ (>75%) | <50 | No | (125) | |
↓ | Not specified | No | (126) | |
– | <10 | No | (65) | |
– | Not specified | No | (99) | |
TNF-α | ↓ (95%) | 20 | Yes (6) | (45) |
↓ | 119 | Yes (4) | (49) | |
↓ | Not specified | No | (99) | |
↓ (>80%) | <50 | No | (125) | |
– | <10 | No | (65) | |
IFN- γ | ↓ | 119 | Yes (4) | (49) |
↓ (>60%) | <50 | No | (125) | |
– | 20 | Yes (6) | (45) | |
IL-7 | ↑ | <10 | No | (65) |
IL-8 | ↑ (41%) | 20 | Yes (6) | (45) |
↑ | 119 | Yes (4) | (49) | |
↑ | Not specified | No | (99) | |
– | <10 | No | (65) | |
– | <50 | No | (125) | |
MCP-1 | ↑ (62%) | 20 | Yes (6) | (45) |
– | <10 | No | (65) |
(↑) A significant increase in cytokine level occurred.
(↓) A significant reduction in cytokine level occurred.
(–) No significant effect on cytokine concentration was observed.
(%) The percentage reduction or increase is noted in brackets.